1. Home
  2. MIST vs FF Comparison

MIST vs FF Comparison

Compare MIST & FF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FF
  • Stock Information
  • Founded
  • MIST 2003
  • FF N/A
  • Country
  • MIST Canada
  • FF United States
  • Employees
  • MIST N/A
  • FF N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FF Major Chemicals
  • Sector
  • MIST Health Care
  • FF Industrials
  • Exchange
  • MIST Nasdaq
  • FF Nasdaq
  • Market Cap
  • MIST 163.2M
  • FF 176.1M
  • IPO Year
  • MIST N/A
  • FF N/A
  • Fundamental
  • Price
  • MIST $1.80
  • FF $3.89
  • Analyst Decision
  • MIST Strong Buy
  • FF
  • Analyst Count
  • MIST 3
  • FF 0
  • Target Price
  • MIST $6.33
  • FF N/A
  • AVG Volume (30 Days)
  • MIST 1.4M
  • FF 196.6K
  • Earning Date
  • MIST 11-11-2025
  • FF 11-10-2025
  • Dividend Yield
  • MIST N/A
  • FF 6.17%
  • EPS Growth
  • MIST N/A
  • FF N/A
  • EPS
  • MIST N/A
  • FF N/A
  • Revenue
  • MIST N/A
  • FF $165,860,000.00
  • Revenue This Year
  • MIST N/A
  • FF N/A
  • Revenue Next Year
  • MIST N/A
  • FF N/A
  • P/E Ratio
  • MIST N/A
  • FF N/A
  • Revenue Growth
  • MIST N/A
  • FF N/A
  • 52 Week Low
  • MIST $0.63
  • FF $3.58
  • 52 Week High
  • MIST $2.75
  • FF $6.30
  • Technical
  • Relative Strength Index (RSI)
  • MIST 40.52
  • FF 46.77
  • Support Level
  • MIST $1.76
  • FF $3.74
  • Resistance Level
  • MIST $1.96
  • FF $3.96
  • Average True Range (ATR)
  • MIST 0.09
  • FF 0.12
  • MACD
  • MIST -0.02
  • FF -0.03
  • Stochastic Oscillator
  • MIST 13.79
  • FF 31.58

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

Share on Social Networks: